Word

ROMVIMZA

Status

Pending

Status Code

688

Status Date

Tuesday, July 23, 2024

Serial Number

98238958

Mark Type

4

Filing Date

Wednesday, October 25, 2023

Published for Opposition

Tuesday, May 28, 2024

Trademark Owner History

Deciphera Pharmaceuticals, LLC - Owner At Publication

Classifications

5 Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors

Trademark Events

Jan 13, 2024

Notification Of Non-Final Action E-Mailed

Oct 28, 2023

New Application Entered

Oct 31, 2023

New Application Office Supplied Data Entered

Jan 12, 2024

Assigned To Examiner

Jan 13, 2024

Non-Final Action Written

Jan 13, 2024

Non-Final Action E-Mailed

Apr 12, 2024

Correspondence Received In Law Office

Apr 12, 2024

Teas/Email Correspondence Entered

Apr 20, 2024

Approved For Pub - Principal Register

May 8, 2024

Notification Of Notice Of Publication E-Mailed

May 28, 2024

Published For Opposition

May 28, 2024

Official Gazette Publication Confirmation E-Mailed

Jul 23, 2024

Noa E-Mailed - Sou Required From Applicant

Apr 12, 2024

Teas Response To Office Action Received